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SUMMARY
CR3 (iC3b receptor), composed of CD1 lb/CD18, is a P2 integrin. A protein that shares antigenic
and structural homology with the at-chain of CD1 lb/CD 18 has been isolated from the surface of
Candida albicans. This molecule is thought to be essential in the pathogenesis of disseminated
candidiasis. To evaluate the effects of anti-iC3b receptor antibodies on adhesion between human
dermal microvascular endothelial cells (HDMEC) and C. albicans, and in treatment of candidal
infection, a binding assay of C. albicans to cultured HDMEC was performed in vitro. An anti-
iC3b receptor-specific monoclonal antibody was administered to mice infected with C. albicans.
The mice were monitored for mortality and renal involvement by culture and histopathological
findings. Flow cytometric analysis demonstrated surface expression of iC3b receptor on C.
albicans. The adherence of C. albicans to HDMEC was significantly decreased by treatment with
anti-iC3b receptor antibodies. Anti-iC3b receptor antibodies significantly increased the survival
time and rate while lowering the renal fungal burden. The iC3b receptors are involved in the
adherence of C. albicans to vascular endothelial cells and are likely to be involved in the
pathogenesis of disseminated candidiasis. The increased survival in mice infected with C. albicans
after treatment with anti-iC3b receptor antibodies indicates that this modality may be beneficial
for future development of a new therapy for candidiasis.
INTRODUCTION
Adherence of a pathogen to host tissue is essential in the
pathogenesis of infectious disease and presumably takes place
in all forms of candidiasis. Studies concerning the modification
or prevention of infection in relation to adhesion mechanisms
have been performed in animal and human models."2 The
virulence of a species of Candida can be correlated with its
ability to adhere to various cell types, with the most virulent
C. albicans being most adherent to epithelial cells. In animal
models of invasive disease, the pathogenicities of candidal
strains in vivo correlate directly with yeast adhesion in vitro.3
Endothelial attachment and subsequent penetration are requi-
site stages in the induction of haematogenously disseminated
candidiasis.
Receptors [complement receptor (CR) 1, CR2 and CR3]
for C3 degradation fragments (C3b, iC3b, C3dg) are present
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on many human cells operative in the immune and inflamma-
tory host defence process and may be critical in the attachment
of invading micro-organisms.3 C3-binding structures are not
specific for mammalian cells in general but can also be found
in micro-organisms pathogenic for humans. CR3 is present on
the surface of mammalian neutrophils, monocytes and phago-
cytes and has been known as CDllb/CD18, Mol, Mac-i, or
iC3b receptor. It is composed of an ao-chain of 165000MW
and a 95000 MW P-chain common to all leucocytes. There
are iC3b receptors on the surface of C. albicans which share
homology with the a-chain of the neutrophilic receptors for
iC3b.-6 Western blotting and immunoprecipitation have con-
firmed the similar relative molecular weights of CR3 on the
human neutrophil and the iC3b receptors isolated from C.
albicans. 6.7
Since in disseminated candidiasis the fungus is delivered to
target organs through the vascular system, targets for adher-
ence of blood-borne fungi ultimately include the endothelial
cell. Experiments on adhesion of C. albicans to cultured human
umbilical vein endothelial cells (HUVEC) demonstrate that
increasing glucose concentrations increase adhesion and mono-
clonal antibodies (mAb) recognizing epitopes on neutrophil
CR3 inhibit glucose-enhanced adhesion of C. albicans to
HUVEC.8 However, the exact role of iC3b receptors in
haematogenously disseminated candidiasis in humans has not
been elucidated.
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Effects ofmAb against iC3b receptors in disseminated candidiasis
We assessed the role of iC3b receptors on C. albicans in
the adhesion of yeast to cultured human dermal microvascular
endothelial cells (HDMEC), and the inhibition of this
adhesion by mAb against iC3b receptors. In addition, we
observed the effects of intravenous injection of anti-iC3b
receptor mAb with respect to mortality and long-term infection
in mice with experimentally induced disseminated candidiasis.
MATERIALS AND METHODS
Organisms
One randomly selected pathogenic strain of C. albicans
(American Type Culture Collection, Rockville, MD; ATCC
44808) recovered from human blood was used for these
experiments. Yeast cells were grown to log-phase in
Sabouraud's broth, as determined by colony counts and spec-
trophotometric measurement ofOD at 420 nm, and were then
frozen at - 700 until use. On the evening before the experiment,
aliquots of frozen yeasts were inoculated into RPMI-1640
media (Gibco Laboratories, Grand Island, NY). After
attaining log-phase growth, the yeasts were pelleted, washed
three times with phosphate-buffered saline (PBS) and diluted
spectrophotometrically to an OD of 0 5 at 420 nm.
Animals
BALB/c mice (Daehan Laboratory Animal Research Centre,
Seoul, Korea) weighing around 25 g were used for all
experiments.
Monoclonal antibodies
Four mAb directed against epitopes on a subunit of CR3 were
Mol (mouse IgM, Coulter Immunology, Hialeah, FL), 44
(mouse IgGl, R&D Systems, Minneapolis, MN), Leu 5
(mouse IgG2a, Becton Dickinson, San Jose, CA), and M1/70.
M1/70 (rat IgG2b) was purchased as a hybridoma (ATCC
TIB 128) and was purified from supernatant by affinity
chromatography on protein G-Sepharose (Hitrap Protein G
column, Pharmacia Biotech, Uppsala, Sweden). The mAb
ECCD-2 (anti-E-cadherin, rat IgG2a) was obtained from
M. Takeichi (Kyoto University, Kyoto, Japan). ECCD-2
was purified from hybridoma supernatants by protein
G-Sepharose affinity chromatography. MEM 48 (mouse IgGI,
R&D Systems, Minneapolis, MN) is a mAb directed against
the common ,B-chain of CR3, leucocyte function associated
antigen-l (LFA-1).
Flow cytometric analysis
Fifty million colony-forming units (CFU)/ml of C. albicans
were washed in PBS with 0-5% bovine serum albumin (BSA),
counted and aliquotted for staining. Primary antibody at the
appropriate dilution was added to each tube. Either an isotype
control mAb or PBS without antibody was used as a first-step
control with identical results. The cells were incubated for
30 min on ice, washed, and second-step antibody, diluted 1/20
in PBS with 0 5% BSA, was added. After another 30 min of
incubation, the cells were washed and resuspended in 0-5 ml
PBS with 0 5% BSA. Propidium iodide was added immediately
before flow cytometric analysis to identify dead cells.
Fluorescence was examined by a Becton Dickinson FACStar
flow cytometer (Becton Dickinson, Mountain View, CA) and
expressed as log mean channel fluorescence.
Isolation and culture ofHDMEC
HDMEC were isolated from human neonatal foreskins by
trypsinization and Percoll gradient centrifugation as described
previously.9"'0 Briefly, foreskins were cut into small pieces,
treated with 0-3% trypsin (Sigma Chemical Co., St Louis,
MD), and 1% ethylenediamine tetraacetic acid (EDTA; Sigma)
and individual segments were compressed with a scalpel
blade to express microvascular fragments. The microvascular
segments were layered onto a 35% Percoll (Pharmacia AB,
Sweden) gradient in Hank's balanced salt solution (HBSS)
and spun at 400 g for 15 min at room temperature. The
fraction with a density less than 1-048 g/mi was applied to
gelatin (Sigma) -precoated tissue-culture dishes and cultured
in endothelial basal media (Clonetics Corp., San Diego, CA)
with epidermal growth factor 1 ng/ml (Clonetics), hydrocorti-
sone acetate 1 gg/ml (Sigma), dibutyryl cyclic AMP 5 x I0-5 M
(Sigma), penicillin 100 U/ml, streptomycin 100 gg/ml, ampho-
tericin B 250 jg/ml (Sigma), and 30% human serum (Irvine
Scientific, Santa Ana, CA). The resulting cell cultures were
free of contaminating fibroblasts as assessed by expression of
CD31 (Fig. 1) and uptake of acetylated low-density lipo-
proteins. Experiments were conducted with endothelial cells
at passages 2-6.
Candida albicans-HDMEC adherence assay
HDMEC were plated in gelatin-coated 96-well flat-bottomed
culture plates. An isolate of C. albicans was grown in the
RPMI medium, labelled with [35S]methionine, washed exten-
sively in PBS and resuspended in HBSS with calcium and
magnesium, to which was added 1% BSA (BSA-HBSS+).
Yeast cells were then held at 40 to prevent germination before
incubation with HDMEC (5% germ tubes present for C.
albicans). Then 4 x 104 CFU were added to each well of
confluent HDMEC monolayer, and incubated for 1 hr at 37°.
For quantification of non-specific bindings, a 100-fold excess
of unlabelled yeast cells were added to labelled yeast cells. The
supernatant was removed from each well and the monolayers
washed twice with BSA-HBSS+ + to remove non-adherent
yeasts. These were counted in a scintillation counter (Beckman
Instruments, Inc., Palo Ato, CA). Adherent yeast cells and
HDMEC monolayers were removed with 1% Triton-X
(Sigma), then solubilized in 0-5 M NaOH and counted in a
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Figure 1. Flow-cytometric analysis showing the expression of CD31
on HDMEC.
© 1997 Blackwell Science Ltd, Immunology, 92, 104-1 10
105
K H. Lee et al.
P-scintillation counter. The percentage binding of C. albicans
was calculated as follows:
C.p.m. (adherent yeasts - non-specific binding) 100
C.p.m. (total yeasts added - non-specific binding)
Inhibition ofadhesion with mAb
C. albicans was grown in RPMI medium and was then
preincubated with 100 pl of mAb to ac-subunit of CR3 for
45 min. 100 g1 of 20 gg/ml of mAb were used. After preincu-
bation with antibodies, the adherence assay was performed as
described above in the continuous presence of antibodies. All
the individual experiments were performed three times
independently.
Experimental infection
Mice were divided into three experimental treatment groups
for the assessment of anti-iC3b receptor antibody on the
resulting prevention of systemic candidiasis. The three groups
were: Group I, controls, received the vehicle for the mAb
(0-5% human serum albumin) and was inoculated with one
dose of 106 CFU of C. albicans grown in RPMI-1640 per
mouse into the lateral tail veins of a group of 45 normal mice;
Group II, mAb Ml/70, beginning before infection received
mAb M1/70 2 mg/kg infused intravenously once per day for
5 days (day 0 to day 5). Group III, isotype control, beginning
before infection received mAb ECCD-2 2 mg/kg infused intra-
venously once per day for 7 days (day 0 to day 5); The fourth
group received only equivalent amounts of mAb M1/70 at the
same time. All animals were monitored for 30 days, and
mortality was recorded. Two groups of 20 mice each were
studied, an only C. albicans-inoculated group and a group
treated anti-M1/70 mAb and inoculated with C. albicans as
previously described. On days 0, 2, 4 and 6, five mice per
experimental group were selected at random and killed by
cervical dislocation. The kidneys of each of these animals were
removed aseptically, transferred into sterile polyethylene bags,
and homogenized in 5 ml of sterile saline. Samples were
removed from each homogenate, serially diluted in 0-9% NaCl,
plated onto Sabouraud dextrose agar plates, and incubated at
250 for 16 hr. The colonies were then enumerated, and CFU
were calculated per gram of each organ. All experiments were
performed in triplicate. To document the administration of
M1/70 mAb sufficient to produce antibody excess, samples of
serum were analysed for the presence of residual M1/70
antibody. Blood was collected from the orbital, venous plexus.
This was assessed by indirect immunofluorescence analysis in
which C. albicans were incubated in serum for 30 min at 250,
and then, after washing, incubated in fluorescein isothiocyan-
ate (FITC)-conjugated goat anti-rat immunoglobulin for an
additional 30 min at 250. Antibody binding to C. albicans was
quantified by flow cytometry. Formalin-fixed portions of kid-
neys obtained at 2, 4 and 6 days were stained with Periodic
acid-Schiff reagent (PAS) to search for fungi in kidneys.
Statistical analysis
All data are expressed as mean + standard error. All differences
in survival were analysed by the Wilcoxon rank sum test and
Kruskal-Wallis test. Product limit method was used to analyse
survival data and repeated ANOVA were applied to compare
the mean CFU per mean kidney weight. Statistical significance
was defined as a P-value of <0 05.
RESULTS
Expression of iC3b receptor on C. albicans
The iC3b receptor expression was observed by immunofluo-
rescence flow cytometry from C. albicans pretreated with anti-
iC3b receptor antibody purified from culture supernatant of
ATCC MI/70 antibody by affinity chromatography (Fig. 2).
Effect of anti-iC3b receptor antibody on adhesion of C. albicans
to HDMEC
Preliminary studies were done to compare the rate of adhesion
between HDMEC and C. albicans according to the number of
C. albicans and elapsed time. The binding of 5 x 105 CFU,
1 x 106 CFU and 2 x 106 CFU of C. albicans to HDMEC were
25-1 +3-8%, 29-9+222% and 283 +1-5%, respectively. The
adherences 30 min, 1 hr and 2 hr after culture were 8 1 + 1 9%,
241 + 37% and 25-4 + 4-9%. The adherence increased signifi-
cantly after 1 hr of culture. Further studies were carried out
under culture conditions with 106 CFU of C. albicans being
cultured for 1 hr.
The adhesion of C. albicans without any prior treatment
to HDMEC was 240+336%. Adherences were 25-4+554%,
27 9 + 1 8%, 26-3 + 0-3% and 16 5 + 2-2% when C. albicans was
treated before inoculation with rat IgG2b, mAb ECCD-2,
anti-CD 18, and M1/70 mAb, respectively (Fig. 3).
Effect of anti-iC3b receptor antibody on mortality in mice with
experimentally induced disseminated candidiasis
Preliminary studies were performed to determine the mortality
rates of BALB/c mice according to the number of C. albicans.
All mice injected with 5 x 106 CFU of C. albicans cultured in
RPMI-1640 media expired within 1 day. At 1 x 106 CFU and
5x 105 CFU, the average survival durations were 27+0-6
days and 43+0-6 days, respectively. Inoculation was done
with 1 x 106 CFU of C. albicans to determine mortality and
effects of the anti-iC3b receptor antibodies. Group I was
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Figure 2. Expression of iC3b receptor on the surface of C. albicans.
Candida albicans was incubated with anti-iC3b receptor mAb anti-
Mol, Leu5, 44 and MI/70 and analysed by fluorescence-activated cell
sorter. The expression of iC3b receptors can be observed on the
surface of C. albicans.
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Figure 3. The effects of anti-iC3b receptor antibodies on the adhesion
of C. albicans to HDMEC. Candida albicans was pretreated with
irrelevant antibody ECCD-2, mAb anti-CD18 against the 1-chain of
iC3b receptor, and M1/70 against the a-chain of iC3b receptor, added
in concentrations of 20 jg/ml at 370 for 45 min, and incubated with
HDMEC monolayer at 37° for 1 hr. Results show the mean
percentage + SD of quadruplicate microtitre wells.
Ml/70 mAb 1 hr prior to inoculation with C. albicans and
Group III was pretreated with mAb ECCD-2 1 hr prior to
inoculation with C. albicans as control. Immunofluorescence
studies revealed strong fluorescence on the surface of C.
albicans collected from the serum of mice 6 days after the
initial inoculation of M1/70 mAb. Fluorescence was observed
on the surface of C. albicans by immunofluorescent flow
cytometry from serum collected 2, 4 and 6 days after
inoculation.
Group IV was injected with only anti-iC3b antibodies and
all 45 mice were alive 30 days after injection. However, all 45








Table 1. Effect of anti-iC3b receptor antibody on duration of survival
in mice with experimentally induced disseminated candidiasis
No. of Survival duration
Inoculation group animals (days)
C. albicans only* 45 2-7+0 7
C. albicans+mAb MI/70t 45 5-3+1 8
C. albicans+control mAbJ 45 3 4+009
mAb M1/70 only§ 45 >30
*Group I was inoculated with only C. albicans.
tGroup II was inoculated with C. albicans and intravenously
injected with anti-iC3b receptor antibody M1/70 at 2 mg/kg of
concentration.
tGroup III was intravenously injected with mAb ECCD-2 at
2 mg/kg of concentration and inoculated with C. albicans.
§Group IV was injected with only anti-iC3b receptor antibody
M1/70.
days after inoculation. All mice in Group II expired between
2 and 10 days after inoculation. However, the mortality rate
in Group II at 4 days after inoculation was 31 1%, which was
significantly lower than the mortality rates at this time in
Groups I and III (P=00001, Fig. 4). The average survival
durations for Groups I, II and III were 2 7 + 0 7 days, 5 3 +1 8
days, and 3 4+0 9 days, respectively, (Table 1). These differ-
ences were significant. White blood cell counts and morphology
of mouse neutrophils were not different between the irrelevant
mAb-treated group and the M1/70-treated group.
Effect of anti-iC3b receptor antibody on renal invasion of C.
albicans in mice with experimentally induced disseminated
candidiasis
To evaluate the effects of anti-iC3b receptor antibody in
disseminated candidiasis, mice were injected intravenously with
5 x 105 CFU of C. albicans cultured in RPMI-1640. The mice
were killed at random and the kidneys were removed, homo-


























Figure 4. Effect of anti-iC3b receptor antibody on mortality of mice
with experimentally induced disseminated candidiasis. Group I was
inoculated with only C. albicans (0). Group II was inoculated with
C. albicans and intravenously injected with anti-iC3b receptor antibody
M1/70 at 2 mg/kg (A). Group III was intravenously injected with
mAb ECCD-2 at 2 mg/kg and inoculated with C. albicans (R). Group
IV was injected with only anti-iC3b receptor antibody M1/70 (V).
The mortality and survival duration of the four groups were compared.
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Figure 5. Effect of anti-iC3b receptor antibody on renal invasion of
mice with experimentally induced disseminated candidiasis. Group I
was inoculated with only C. albicans. Group II was inoculated with
C. albicans and intravenously injected with anti-iC3b receptor antibody
M1/70 at 2 mg/kg. Renal specimens were harvested every 2 days for
6 days to evaluate the invasion of kidneys. A quantitative culture
assay was performed three times for each mouse. The average CFU
of C. albicans/g of kidney were compared.
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Figure 6. (a) Histopathological findings of kidney of mice with expernmentally induced disseminated candidiasis and treated with
anti-iC~b receptor antibody (PAS stain x 40). (b) Higher magnification (x 400). Group I was inoculated with only C. albicans.
Group II was inoculated with C. albicans and intravenously injected with anti-iC~b receptor antibody Ml/70 at 2 mg/kg. Renal
specimens were harvested every 2 days for 6 days to Ievaluate the invasion of kidneys. Specimens were paraffin-embedded and
stained with periodic Schiff reagent. This staining revealed many fungal spores and hyphae in the glomerulus at the second day of
infection in Group I, whereas Group II showed only few fungal spores and hyphae. G-1-2, Group I-day 2; G-I14, Group I-day 4;
G-I-6, Group I-day 6; G-1I-2, Group II-day 2; G-11-4, Group Il-day 4; G-II-6, Group Il-day 6.
C 1997 Blackwell Science Ltd, Immunology, 92, 104-110
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Effects ofmAb against iC3b receptors in disseminated candidiasis
On the days 2, 4 and 6 of infection, Group I had
3 0+0-2 x 109 CFU, 3-3+ 1-8 x 109 CFU, 3 2+O1 x 107 CFU
of C. albicans, respectively, in 1 g of kidney. By comparison,
Group II had [*6 +1 3 x 106 CFU, 28 +l1-2 x 105 CFU,
1-9+1-2 x 105 CFU of C. albicans, respectively, in 1 g of
kidney. These differences in renal involvement were statistically
significant (P=0-0001, Fig. 5).
Periodic acid-Schiff staining of the extracted renal speci-
mens revealed many fungal spores and hyphae in the renal
medulla on day 2 of infection in Group I. Group II showed
only a few fungal spores and hyphae on day 2 of infection.
Group I showed heavy infiltration of inflammatory cells at the
sixth day of infection (Fig. 6).
DISCUSSION
The importance of the adherence of Candida in the pathogen-
esis of disseminated disease is increasingly recognized. There
have been reports that pathogenicity of candidal strains in vivo
correlate directly with yeast adhesion in vitro.' However,
studies on fungus-to-host cell adhesion mechanisms have been
relatively sparse. It is possible to categorize these adhesion
mechanisms by considering the components of each ligand-
receptor.'1 The first category includes protein-protein inter-
actions such as the iC3b receptor on C. albicans. The second
category includes interactions in which a surface Candida
protein with lectin activity recognizes sugar residues associated
with the host-cell plasma membrane. The third category
involves a carbohydrate ligand, mannan, on the Candida cell
surface that is recognized by an unknown host-cell receptor.
Complement fragments adhere more readily to Candida than
to endothelial cells in vitro.4'2 CR3 on neutrophils is involved
in recognition of iC3b on the surface of micro-organisms and
subsequent phagocytosis. The iC3b receptor on the surface of
C. albicans has recently been isolated and characterized.'3 The
iC3b receptor in Candida shares antigenic and structural
homology with CR3 on neutrophils.46
As we, and others, have observed the expression of iC3b
receptor is usually below 50% depending on the type of mAb
used, condition of culture medium, species or strains of
Candida used, etc.5 6'8"12 The low expression in our study was
due to the RPMI medium with low glucose concentration.
When the glucose concentration was increased, the expression
of iC3b receptor was up-regulated (unpublished results).
However, the difference in the expression could be attributed
to the type of mAb used.
The relationship between hyperglycaemia and candidal
infection has been well documented.14 However, the exact
mechanism by which sensitivity to candidal infection is
increased is unknown. There have been reports that expression
of iC3b receptor on Candida and adhesion to cultured HUVEC
correlate with glucose concentrations.5 6 Moreover, adhesion
to cultured HUVEC is suppressed by 50-80% with mAb
directed against the ac-chain of the iC3b receptor.8
As there are marked differences between the endothelial
cells of various vessels,9"10"15 and as C. albicans infects the skin
and mucous membranes easily, we performed adhesion experi-
ments using cultured HDMEC isolated from skin. Our results
show that adherence of C. albicans correlates with reaction
time and number of organisms. But there was a marked
decrease when anti-iC3b receptor mAb were added. These
findings are similar to previous studies using HUVEC.8
Intercellular adhesion molecule-l (ICAM-1), which acts as
a ligand for neutrophil CR3, has no role in the adhesion of
iC3b receptor on C. albicans.8"6 Recently, the host ligand for
the iC3b receptor on C. albicans has been characterized as
iC3b."' C3 is synthesized from endothelial cells'8 and it is
plausible to assume that C3 is degraded by proteolytic enzymes
in the serum or cell with the resultant iC3b attaching to the
endothelial surface and acting as a ligand for the iC3b
reetr7,18,19
receptor.7""
In the present study, binding of C. albicans to HDMEC
was partially inhibited by mAb M1/70. This would be
explained by the finding of 50 000, 100 000, 130 000 and 165 000
MW proteins in extracts of C. albicans reacting with anti-iC3b
receptor antibodies in immunoblotting and immunoprecipit-
ation studies.6'7 Hence, the combination of this variability of
the iC3b receptor epitopes and specificity of each mAb might
have resulted in the partial inhibition as seen in our study.
We confirmed that the iC3b receptor on C. albicans is
essential for adhesion to cultured HDMEC. Thus we assumed
that prevention of the yeast-to-host cell adhesion could block
the dissemination of Candida to surrounding tissue. haemato-
genously disseminated candidiasis was induced in mice by
intravenous injection with C. albicans. The mortality rate of
the group injected with anti-iC3b receptor mAb was signifi-
cantly lower than that of the normal control. The 50% survival
rate increased significantly. The amount of yeast and the extent
of invasion of renal tissue was significantly less. The affinity
constant for the iC3b receptor is 2-1 + 0 5 x 106 L/M for human
neutrophils20 and virtually identical to that of C. albicans.5
However, Candida possess 2 x 106 iC3b receptors per yeast
which is nearly 100 times higher than neutrophils.5 The
increased survival rate in mice treated with anti-iC3b receptor
antibodies indicates that this modality might be beneficial for
future development of a new therapy for disseminated
candidiasis.
The iC3b receptor on Candida is homologous in srtucture
to human CR3, however, it is not the same molecule. There
is no doubt that antibodies directly against the Candida iC3b
receptor would be likely to bind better to Candida and to have
better inhibitory effects. However, at this time, we could not
obtain the purified candidal iC3b receptor and its mAb. It is
desirable that similar experiments using the above antibody
be carried out as a next step to evaluate the clinical usefulness
of anti-iC3b receptor antibody in the treatment ofhaematogen-
ous candidiasis.
The anti-iC3b receptor mAb may have deleterious effects
on host neutrophils and aggravate the course of disease, but
our in vivo results indicate that they have a therapeutic effect
in haematogenously disseminated candidiasis without signifi-
cant alterations in host neutrophils. Attachment to the iC3b
receptor on C. albicans blocks adhesion to endothelium and
subsequent systemic invasion. Adherence to the endothelium
is correlated with virulence. However, it is too early to discuss
the interactions between intravenously injected C. albicans and
the anti-iC3b receptor mAb based solely on the current
experiment. We plan to use radioisotope-labelled anti-iC3b
antibodies for future studies and to evaluate the safety profiles
of anti-iC3b mAb in humans.
1997 Blackwell Science Ltd, Immunology, 92, 104-110
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